Your browser doesn't support javascript.
loading
Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.
Thomas, Anusha S; Ma, Weijie; Wang, Yinghong.
Affiliation
  • Thomas AS; University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Ma W; Zhongnan Hospital, Wuhan, China.
  • Wang Y; University of Texas M.D. Anderson Cancer Center, Houston, TX ywang59@mdanderson.org.
N Engl J Med ; 384(6): 581-583, 2021 02 11.
Article in En | MEDLINE | ID: mdl-33567198
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Ustekinumab / Immune Checkpoint Inhibitors Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Ustekinumab / Immune Checkpoint Inhibitors Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2021 Type: Article